| |
| |
|
| Insider
Information: |
Saxe Jon S |
| Relationship: |
|
| City: |
Cupertino |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
572,241 |
|
|
Indirect Shares
|
200,000 |
|
|
| Direct
Value |
$5,838,417 |
|
|
|
Indirect Value
|
$417,500 |
|
|
| Total
Shares |
772,241 |
|
|
| Total
Value |
$6,255,917 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 211.1%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Durect Corp |
DRRX |
Director |
2019-06-10 |
27,810 |
2019-06-10 |
150,000 |
Premium* |
|
|
Incyte Corp |
INCY |
Director |
2004-03-30 |
80,000 |
2004-03-30 |
0 |
Premium* |
|
|
PDL Biopharma Inc |
PDLI |
Director |
2008-04-09 |
421,680 |
2004-11-01 |
0 |
Premium* |
|
|
Insite Vision Inc |
INSV |
Director |
2007-09-13 |
37,000 |
2007-09-13 |
0 |
Premium* |
|
|
Sciclone Pharmaceuticals Inc |
SCLN |
Director |
2017-10-13 |
0 |
2007-11-20 |
0 |
Premium* |
|
|
Vistagen Therapeutics Inc |
VTGN |
|
2021-03-19 |
5,751 |
2021-03-19 |
50,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
56 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DRRX |
Durect Corp |
Director |
– • – |
2019-05-13 |
4 |
B |
$0.68 |
$28,095 |
I/I |
40,400 |
85,400 |
2.1 |
- |
|
| DRRX |
Durect Corp |
Director |
– • – |
2019-05-13 |
4 |
B |
$0.70 |
$6,773 |
I/I |
9,600 |
95,000 |
2.1 |
- |
|
| DRRX |
Durect Corp |
Director |
– • – |
2019-05-24 |
4 |
B |
$0.63 |
$18,903 |
I/I |
30,000 |
125,000 |
2.1 |
- |
|
| DRRX |
Durect Corp |
Director |
– • – |
2019-06-10 |
4 |
B |
$0.54 |
$13,750 |
I/I |
25,000 |
150,000 |
2.1 |
- |
|
| VTGN |
Vistagen Therapeutics Inc |
|
– • – |
2020-08-21 |
4 |
B |
$0.69 |
$20,700 |
I/I |
30,000 |
50,000 |
0.01 |
% |
|
| VTGN |
Vistagen Therapeutics Inc |
|
– • – |
2021-03-19 |
4 |
OE |
$1.50 |
$3,750 |
D/D |
2,500 |
5,751 |
0 |
- |
|
56 Records found
|
|
Page 3 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
